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Diagostic value of respiratory impedance
measurements in elderly subjects
J. P. JANSSENS, M. C. NGUYEN, F. R. HERRMANN AND J. P. MICHEL
Department of Geriatrics, Geneva University Hospitals, Geneva, Switzerland
Obstructive lung disease (OLD) is highly prevalent in elderly subjects but markedly under-diagnosed. Indeed, only
40–50% of hospitalized elderly patients are able to adequately perform spirometric tests. This study aimed to
evaluate, in an acute-care geriatric hospital, the diagnostic value of measuring airway impedance (Zrs) by the forced
oscillation technique (FOT) for: (1) identifying OLD and (2) identifying responders vs. non-responders to
bronchodilators.
Sixty-seven patients (aged 82+8 years) underwent consecutive measurement of Zrs and forced expiratory
volumes before and after bronchodilators. Zrs was measured by FOT at frequencies of 4–30Hz. Correlations, ROC
curves and logistic regression models were established to determine the sensitivity (Se) and specificity (Sp) of Zrs in
identifying OLD.
Significant correlations were found between spirometric and Zrs measurements. The Zrs parameters yielding the
best Se and Sp for detecting OLD were: Fn (resonant frequency; Se: 76%; Sp: 78%) and R0 (resistance extrapolated
for a frequency of 0: Se: 76%; Sp: 74%). Using the logistic regression models, 76% of the patients were correctly
classified as having OLD or not. Zrs was however not contributive in identifying responders to bronchodilators.
Zrs measurements by FOT are contributive to the diagnosis of OLD in elderly hospitalized patients.
Key words: elderly; aged; respiratory impedance; respiratory resistance; forced oscillation technique; airway
obstruction; pulmonary function tests.
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Obstructive lung disease (OLD) is a frequent problem in the
elderly (1). However, OLD is under-diagnosed and under-
treated in this age group (2). One reason is the diculty
older subjects encounter in adequately performing pulmon-
ary function tests (PFT): the feasibility of spirometry may
drop to 20% in institutionalized or hospitalized elderly
patients with moderate or severe cognitive impairement (3).
Indeed, the prevalence of dementia increases with ageing,
reaching 5?6% after the age of 75, and 22% after 80 years
(4).
Carvalhaes-Neto et al. (3) showed that measuring
impedance of the respiratory system (Zrs) by the forced
oscillation technique (FOT) was feasible in elderly institu-
tionalized patients, even with moderate to severe cognitive
impairement, potentially allowing identification and quan-
tification of airway obstruction. In their study, only 40% of
the subjects tested could perform spirometry vs. 76% for
Zrs; however, the sensitivity of FOT for detecting airwayReceived 4 September 2000 and accepted in revised form 19
February 2001.
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0954-6111/01/050415+08 $35?00/0obstruction, or reversibility of obstruction in the very old,
was not determined.
In this study, our purpose was to evaluate, in elderly
patients hospitalized in an acute-care geriatric hospital, the
contribution of Zrs by FOT in: (1) identifying patients with
vs. without airway obstruction and (2) identifying respon-
ders vs. non-responders to bronchodilators.
Patients and methods
This study was performed in a 304-bed acute-care geriatric
teaching hospital [2940 admissions per year; mean age of
patients admitted: 84+6 years (SD), all aged over 65 years].
All patients for whom PFTs were requested by the
attending physician were eligible for inclusion. Exclusion
criteria were: presence of an acute medical disorder
interfering with the capacity to perform PFT and incapacity
of assuming a sitting position.
The first part of the study was performed between
January and August 1999: 192 patients (group A, Table 1)
were referred for pulmonary function testing either because
of dyspnoea (suspicion of OLD) or as an elective evaluati-
on before a surgical procedure. To determine the sensiti-
vity, specificity and threshold values of FOT parameters
for identifying OLD, spirometry and Zrs measurements
were compared from data obtained in a subgroup of# 2001 HARCOURT PUBLISHERS LTD
TABLE 1. Descriptive statistics of patients studied
Group A (n=192)
mean+SD





Age (years) 82?7+7?3 82?1+7?6 82?9+7?3
Body mass index (kgm72) 24?7+4?6 24?4+4?9 24?0+4?2
MMSE 24?7+5?0* 27?3+2?0 26?7+2?3
FEV1 (l) 1?34+0?57 1?44+0?61 1?27+0?57
FEV1 (% predicted) 77?7+32?9 79?9+31?7 72?9+31?2
FEV1/FVC (%) 75?5+15?3 75?2+14?1 71?2+12?9**
FEV1/FVC (% predicted) 97?7+20?4 96?9+18?7 90?2+17?7
PEF (lmin71) 218+104* 251+109} 205+93
R0 (cmH2O l
71. sec) 3?41+1?40 3?25+1?08 3?37+1?13
R0 (% predicted) 122+46 117+35 120+37
RM (cmH2O l
71. sec) 3?09+1?02 2?94+0?75 2?92+0?88
RM (% predicted) 103+34 99+24 97?8+29?3
R4–16 (cmH2O l
71. sec) 3?22+1?14 3?07+0?87 3?09+0?97
R4-16 (% predicted) 111+37 106+28 106+32
Fn (Hz) 12?9+6?4 13?1+4?7} 14?9+4?9**
Fn (% predicted) 136+65 139+48} 159+53**
Group A: 192 subjects referred for pulmonary function testing; group B: 67 patients from group A with a MMSE score (mini-
mental state examination) above 23 and adequately performed spirometry; group C: additional group of 48 patients fulfilling
inclusion criteria of group B and used for validation of logistic regression models generated from group B (see Appendix).
* Unpaired t-test, P50?05 between groups A and B; ** P50?05 between groups A and C; } P50?05 between groups B and C;
no significant difference between groups for all other parameters.
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who adequately performed spirometry (group B, n=67,
Table 1). During the second part of the study (September to
December 1999), 48 patients (group C, Table 1), fulfilling
inclusion criteria of subjects in group B, were included for
validation of logistic regression models generated from
group B.
The study protocol was approved by the Ethics
Committee of the University Hospital of Geneva.
ASSESSMENT OF RESPIRATORY FUNCTION
Forced expiratory volumes were recorded using the
Oscilink1 combined spirometer/impedancemeter (Data-
link1, Montpellier, France). Forced expiratory volume in
1 sec (FEV1), forced vital capacity (FVC), peak expiratory
flow (PEF) and expiratory flow–volume curves were
recorded with Pulmowin1 software. A minimum of three
manoeuvres were performed, the best values being recorded
for each parameter. Reference values were published by
Quanjer et al. (5). Spirometric testing was considered
acceptable if fulfilling ATS criteria (6).
Zrs measurements by FOT were performed with the
Oscilink1 spirometer/impedancemeter derived from the
prototype described by Carvalhaes-Neto et al. (3), coupled
with Pulmowin1 software.
A calibration for pressure and flow was performed before
each new patient. Zrs measurements were performed
according to published recommendations (7). Duringmeasurements, the patient was seated, and was asked to
breathe normally through a mouthpiece, with a nose-clip,
for a total of 17 sec. The patients’ breathing was visualized
and monitored ‘on-line’. The position of the subject was
carefully monitored (7,8); the hands of the technician were
applied on both cheeks during the manoeuvre in order to
avoid upper airway artifacts (7,9). A pseudorandom noise
(27 harmonics of 1Hz: 4–30Hz) was generated by a
loudspeaker, applied to the mouth, and superimposed on
the patient’s spontaneous breathing. Two ‘Validyne’
pressure transducers were used for Zrs measurements; one
measured pressure at the mouth. The other was connected
to a Hans–Rudolf pneumotachograph, which simulta-
neously recorded variations in pressure and flow; both
these signals were filtered for low (53Hz) and high
frequency components, to eliminate the so-called leakage
error caused by the presence of breathing noise (7,9,10),
and processed by computer using a fast Fourier analysis, a
mathematical tool which can resolve any wave form into its
individual frequency components (11). Data recorded were
averaged over four consecutive 4-sec breathing periods.
Zrs is partitioned into a real part (resistance: Rrs) and
an imaginary part (reactance: Xrs). Spectral analysis of
the pressure and flow signals yielded the mean resistance
over the entire frequency range (RM, cmH2O l
71. sec),
the mean resistance between 4 and 16Hz (R4–16,
cmH2O l
71. sec), the slope of the linear relationship
between resistance and frequency (S, cmH2O l
71. sec), and
the resistance extrapolated for Hz=0 (R0, cmH2O l
71.sec),
using a linear regression method (R=R0+S6f, where
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Rrs and Xrs as a function of frequency. From this last
graph, the resonant frequency (Fn,Hz) was derived
(frequency at which Xrs=0). Parameters analysed were
RM, R4–16, R0 and Fn.
The Pulmowin1 software did not include a coherence
function (which decreases the variability of Zrs measure-
ments) (12). Particular attention was given to monitoring
resting ventilation, and excluding blocks of data with
irregular breathing, coughing, hyperventilation, apnoea, or
leaks through mouthpiece. Measurements were repeated an
average of 3–5 times (up to 10 times if necessary) until three
consecutive measurements showed adequate reproducibil-
ity. This was assessed on the basis of the graphs: (Rrs vs.
frequency) and (Xrs vs. frequency) immediately available
with the Pulmowin1 software; these three measurements
were recorded and coecients of variation were calculated
for R0, RM, R4–16 and Fn.
OLD is expected to increase Rrs, mainly at frequencies
below 16Hz (negative frequency dependance of Rrs),
decrease Xrs (not analysed) and increase Fn. The coecient
of variation of measurements of Zrs by FOT is estimated to
be between 9% and 17% (13,14). Predicted values for Zrs
were published by Pasker et al. (15).
STUDY PROTOCOL
Patients included underwent consecutive measurements of
Zrs and forced expiratory volumes always in the same
sequence (Zrs first), under the supervision of a specially
trained nurse. Bronchodilator treatment was withheld for
at least 6 h prior to testing for short-acting b2-agonists and
at least 12 h for long-acting b2-agonists. After initial testing,
the patients received albuterol (200mg) and ipratropium
bromide (40mg) through a spacer (Volumatic1). All three
measurements were repeated after 60min, to obtain the
additive effect of both bronchodilators.
Patients were considered as having OLD if FEV1/FVC
was 5 90% of predicted. They were considered as having
reversible OLD if increase in FEV1 was at least 15% of
initial value, and more than 200ml (6).
ASSESSMENT OF COGNITIVE FUNCTION
We used the mini-mental state examination (MMSE) to
screen for cognitive impairement, a brief, physician-
administered examination of orientation, memory, atten-
tion, naming, comprehension and praxis; scores range from
0 (lowest) to 30. Scores above 23 are considered ‘normal’;
between 17 and 23, patients have mild cognitive
impairment; patients with scores under 17 have severe
impairment (17).
STATISTICAL ANALYSIS
Stata Statistical Software (Release 5.0, 1997, Stata Cor-
poration, College Station, Texas) was used for statistical
analysis. Pearson’s coecients of correlation were used
to compare parametric variables. For analysing relation-ships between FEV1 and FOT parameters (i.e. RM, R4–16,
R0 and Fn), we computed inverse linear regressions
(y=a/x+b). Unpaired t-tests were used to compare
parametric data between groups. Chi-square tests were
used to compare nominal data. Limit of significance was
set at 0?05.
To determine how Zrs measurements could discriminate
between patients with vs. without OLD, we constructed
receiver operating characteristic (ROC) curves for the
following indices: RM, R0, R4–16 and Fn. The ROC curves
show, for each parameter tested, the sensitivity and the
false-positive rate (1—specificity) over a range of possible
threshold values (18). The performance of a test can be
described by computing the area under the ROC curve
(AUC), with an ideal test having an AUC of 1?0 and a
useless test having an AUC of 0?5.
A logistic regression model was calculated for each of the
following parameters: RM, R4–16, R0 and Fn, and for their
combination, yielding the probability of presence or
absence of bronchial obstruction. These equations were
subsequently tested in an independent group of 48 elderly
patients (group C) for external validation (18) (see
Appendix and Table 1).
Results
PATIENTS
One hundred and ninety-two patients were included in
group A (74 men, 118 women, aged 82.7+7?3 years:
mean+SD) (Table 1). Cognitive impairment was severe
(MMSE5 17) in 11 patients (5?7%), and mild
(17MMSE23) in 56 patients (29%); 125 (65%) had
normal MMSE scores. Amongst all patients, 150 (78%)
complained of dyspnoea.
Only 97 patients (50?5%) could adequately perform
spirometry. No significant relationship was found between
cognitive impairment (MMSE) and feasibility of spirometry
(P=0?11). Feasibility of Zrs measurements (defined as
subjects in whom coecients of variation for RM, R0,
R4–16 and Fn were all 5 20%) was 73?8% (n=141
subjects). Feasibility rates were significantly different
between patients with a MMSE423 vs. 23 (79% vs.
64%, P=0?04), although no difference was noted between
subjects with a MMSE4 17 vs. 17 (66% vs. 63%;
P=0?97).
To determine the threshold values for identifying OLD
for each of the parameters of Zrs, spirometry and Zrs
measurements were compared from data obtained in
patients who performed spirometry according to ATS
criteria (6) and had a MMSE4 23 (group B, Table 1).
Indeed, Carvalhaes-Neto et al. showed that having a
MMSE4 23 was associated with a feasibility rate of Zrs
measurements close to 100%. Conversely, MMSE scores
below 23 were associated with a rather rapid decline in
feasibility rate of Zrs measurements (3). This selection of
patients allowed therefore a comparative analysis of
spirometry with optimally performed Zrs measurements.
Sixty-seven patients met both criteria (group B: 27 men, 40
TABLE 2. r2 values for correlations between spirometric values and respiratory impedance (absolute values) with level of
significance (P-values)
n=67 FEV1 P-value FEV1/FVC P-value PEF P-value
R4–16 0?31 50?001 0?13 0?040 0?25 50?001
R0 0?34 50?001 0?16 0?010 0?27 50?001
RM 0?26 50?001 0?09 0?180 0?21 0?001
Fn 0?41 50?001 0?14 0?020 0?27 50?001
TABLE 3. r2 values for correlations between spirometric
values and Zrs measurements (as % of predicted) (with level
of significance)
n=67 FEV1 P-value FEV1/FVC P-value
R4–16 0?12 0?03 0?17 0?003
R0 0?21 0?001 0?25 0?000
RM 0?05 0?397 0?10 0?047
Fn 0?21 0?002 0?21 0?002
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25 (37%) had OLD.
Coecients of variation for Zrs measurements (n=67,
group B) were: 7?9+4?4% for R4–16; 8?8+4?7% for R0;
7?8+4?9% for RM; and 9?6+5?8% for Fn.
Correlations between Zrs and spirometric data are shown
in Table 2 (absolute values) and Table 3 (values as %
predicted). Correlation coecients obtained between abso-
lute values of spirometric tests and Zrs were higher than
those obtained with values as % predicted. No correlations
were computed between PEF (% predicted) and Zrs because
of the lack of reliable reference values for PEF in the very
old. The two parameters showing the most significant
correlations with FEV1 or FEV1/FVC (% predicted) were
R0 and Fn.
Because of the possibility of a non-linear relationship
between FOT parameters and FEV1 (Figs 1 and 2), inverse
linear regressions were computed; equations for R0 and Fn
as well as r2 values are included in legends of figures 1 and
2; r2 values were respectively: r2=0?27 for RM and r
2=0?31
for R4–16. Values for r
2 using inverse linear regressions were
slightly higher than r2 values for linear regressions shown in
Table 2.
ROC curves are shown for R4–16, RM, R0 and Fn (all
values as % predicted) (Fig. 3). AUC values were: 0?733 for
R4–16; 0?784 for R0; 0.685 for RM; and 0?791 for Fn. The
point of the ROC curve closest to the ideal point was also
determined, and values of sensitivity, specificity and
thresholds for each parameter tested are given in Table 4.
Using the logistic regression equations with a cut-off
value for probability of OLD of 0?5, 76% of patients were
correctly classified as ‘obstructive’ or ‘non-obstructive’ on
the basis of R0 values, 75% on the basis of FN values, 72%
on the basis of R4–16 values, and 71% on the basis of RM
values.
VALIDATION OF REGRESSION
EQUATIONS: (SEE APPENDIX FOR
EQUATIONS)
The validity of the models established on the initial study
group was tested on an independent group of 48 patients
(group C, Table 1); 18 patients (37%) had OLD in this
group. A computation of ‘goodness of fit’ (L-fit test)
showed that the sensitivity and specificity of the equations
established for group B (test group, Table 1) did not changesignificantly in the validation group (group C); these
equations were therefore validated (16).
RESPONSE TO BRONCHODILATORS
Table 5 shows the correlations between changes in FEV1 or
PEF, and changes in R4–16, RM, R0 or Fn (expressed as %
of initial value), calculated for subjects with significant
reversibility of obstruction after bronchodilators (n=25).
None of these changes reached statistical significance. We
also performed a 262 table analysis, defining as ‘responsive
to bronchodilators’ patients having a 25% decrease in
airway resistance or a 12% increase in FEV1 (with a
minimal increment of 200ml): no significant association
between improvement in Zrs parameters and improvement
in FEV1 was found (for R4–16: P=0?60; for RM: P=0?60;
for R0: P=0?29; and for Fn: P=0?99).
Discussion
In the present study, we have shown that measurement of
Zrs by FOT has a higher feasibility rate than spirometry in
elderly subjects hospitalized in an acute-care geriatric
hospital, even in the presence of cognitive impairment:
73?8% of the patients tested could adequately perform Zrs
measurements; however, only 50?5% of the patients studied
could correctly perform spirometry. Furthermore, Zrs
measurements by FOT could correctly identify 75% of
patients suffering from OLD, with a sensitivity (using Fn)
of 76% and a specificity of 78% (Table 4, Fig. 3). Fn and
R0—accounting for the negative frequency dependance of
Rrs—were the parameters with the best Se and Sp. Zrs
FIG. 1. Inverse linear regression between R0 (resistance
extrapolated for a frequency of 0) and FEV1 (absolute
values); regression equation: FEV1=0?4427+2?914/R0.
r2=0?34; P50?0001; n=67 patients.
FIG. 2. Inverse linear regression between resonant




FIG. 3. ROC (receiver operating characteristic curves) for
RM (^), R0 (&), R4–16 (~), and Fn (*); all curves are
computed with values as % of predicted. The point of the
curves nearest to the upper left corner yields the optimal
combination of sensitivity and specificity; corresponding
values of RM, R0, R4–16 and Fn are given in Table 4.
TABLE 4. Diagnostic value of Zrs measurements by FOT for
identifying obstructive lung disease: sensitivity and specifi-
city of R4–16, RM, R0 and Fn for optimal threshold values
n=67 Sensitivity Specificity Threshold value
(% predicted)
R4–16 0?72 0?74 105
R0 0?76 0?74 115
RM 0?72 0?74 100
Fn 0?76 0?78 138
TABLE 5. Correlations (and level of significance) between
changes in ZRS and changes in FEV1 and PEF after
inhalation of albuterol and ipratropium, in 25 patients with
significant change in FEV1 after bronchodilators
n=25 DFEV1 P-value DPEF P-value
DR4-16 70?130 1?00 70?050 1?00
DR0 70?100 1?00 0?010 1?00
DRM 70?140 1?00 0?060 1?00
DFn 70?140 1?00 0?060 1?00
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FEV1/FVC and PEF in this age group (Tables 2 and 3),
although with considerable variability of individual results
around the regression lines (Figs 1 and 2).
The main advantage of FOT measurements in this age
group, when compared with spirometry, is their relative
ease because of the lack of forced expiratory manoeuvres,
and the decreased fatigue for the patient. Measurements are
however on the average as time-consuming as spirometry.
Measurement of Zrs by FOT has been studied in infants
and children (19–21), in asthmatic children admitted to an
emergency ward (22), in intubated patients with or withoutpositive end-expiratory pressure (PEEP) (23), in testing for
bronchial response to bronchodilators, histamine or carba-
chol (14,24), in epidemiological studies of occupational
lung diseases (25,26), in left ventricular dysfunction (27),
and in chornic obstructive pulmonary disease (COPD)
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Neto et al. (3) and this study are the only evaluations
of the clinical usefullness of measuring Zrs by FOT in the
very old.
Comparisons between the results presented and pub-
lished data are limited by the wide variability in techniques
and equipment used and in the populations studied.
However, correlations obtained between spirometric data
and Zrs (Table 2) are very similar to those published in
previous studies using a similar range of frequencies
(4–32Hz) either in elderly subjects (3) or in younger adults
(24,25). Of the four available publications analysing the
performance of FOT in detecting OLD by ROC curves
(20,21,24,25), only one (25) studies an adult population,
using ‘FEV1 90% predicted’ to define the presence of
OLD :ROC curves were similar to our data for RM, R0 and
Fn. The results presented therefore appear quite compar-
able to data published in younger adults.
Zrs measurements were adequately performed in 73?8%
of the patients studied: this is in agreement with a feasibility
rate of 76% noted by Carvalhaes-Neto et al. in 208 elderly,
institutionalized subjects (3). As noted by these authors,
feasibility of Zrs measurements was significantly related to
cognitive impairment but remained higher than spirometry
even in cognitively impaired subjects (79% vs. 64% for
patients with MMSE4 vs. 23); feasibility of spirometry
was slightly higher in our study (50?5% vs. 40?9%); the
absence of significant relationship between feasibility of
spirometry and MMSE in our study is probably related to
the difference in prevalence of marked cognitive impair-
ment (MMSE 23) between both studies (35% in the
present study vs. 78%): this relationship has been pre-
viously convincingly demonstrated (3) and was not a goal
of this study.
Correlations between spirometry and Zrs improved when
computed with absolute values vs. values as per cent of
predicted. This raises the issue of the quality of the
reference values: those supplied with Pulmowin1 software
contained regression equations based on subjects 18–70
years of age, and reference values for the very old were
therefore extrapolations (15). To date however, we are not
aware of any published database of reference values for
FOT parameters in elderly subjects (i.e. aged 70 years): a
database encompassing data for subjects aged4 70–75
years of age is mandatory to improve the clinical
performance of FOT measurements in this age group.
Despite this limitation, ROC curves and threshold values
were calculated as per cent of predicted to take into account
the variation of normal values of Zrs as a function of sex,
age, height and weight.
A possible limitation of the instrument tested was the
absence of a coherence function. The coherence function
(g2) evaluates differences between input and output which
may be caused by extraneous ‘noise’ (such as noise
generated by spontaneous breathing) (11). Most publica-
tions on Zrs measurements by FOT refer to the use of a
coherence function, although threshold values for g2 vary
markedly (0?8–0?95). Determining high threshold values for
the coherence function tends to decrease the number of
valid measurements obtained at low frequencies. However,averaging resistance and reactance over several respiratory
cycles—as performed by the Pulmowin1 software—tends
to compensate for the absence of a coherence function (29).
Indeed, the coecients of variation (CV) of Zrs measure-
ments performed in the present study were either within or
below the range of published values of CV for this
technique (13,14).
Several studies have shown that Zrs measurements by
FOT detect changes in bronchial obstruction induced
either by bronchodilators, or by inhalation of carbachol
or histamine, in children (19,21), and in younger adults
(24,26,30). However, this was not the case in the present
study: no significant correlation was found between
changes in Zrs and changes in spirometric parameters
(Table 5). Indeed, Gimeno et al. (13) showed, in COPD
patients aged 55–75 years, that variations in airway
resistance up to 26% (i.e. clearly above CV values for
younger subjects with or without COPD) can be considered
as ‘spontaneous variability’: ageing may therefore be
associated with an increased CV of FOT; noteworthy
also is the report of a marked drop in sensitivity of FOT
in patients with severe obstruction (31): lower FEV1
values in elderly subjects may contribute to a decreased
sensitivity of FOT in detecting changes in bronchial
obstruction.
Conclusion
Measurement of Zrs by FOT has a high feasibility rate
in elderly hospitalized patients, even in the presence
of cognitive impairment, it’s main advantage being the
lack of forced expiratory manoeuvre and the simplicity of
the test. As in younger subjects, Zrs was significantly
correlated with spirometric measurements. Fn and R0 were
the parameters with the highest sensitivity and specificity
for identifying OLD. Because of the low feasibility rate of
spirometry in hospitalized or institutionalized elderly
subjects, Zrs measurements by FOT are clearly contributive
to diagnosing OLD in this population. Further studies
are warranted to evaluate the clinical contribution of
different frequencies or frequency ranges, and to establish
normal reference values for this age group. In the present
study, FOT was however not contributive in identi-
fying elderly patients with a significant response to
bronchodilators.
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Appendix
LOGISTIC REGRESSION MODELS FOR
EACH PARAMETER OF ZRS, VALIDATED IN
AN INDEPENDANT GROUP OF 48
PATIENTS (GROUP C)
The logistic regression equations describe the relationship
between the probability of an event (i.e. having OLD or
not, values from 0 to 1) and the values of one or more
422 J. P. JANSSENS ET AL.variables studied. Logistic regression analysis was applied
for each parameter in order to perform a sensitivity (Se)
and specificity (Sp) analysis and determine the ‘best’
parameter amongst those studied. Because the parameters
studied have a significant correlation between themselves,
performing a multiple logistic regression encompassing all




where P=probability of OLD and ea=odds ratio.For R4–16 as % predicted: a=74?0243+0?03216R4–16
For R0 as % predicted: a =74?6405+0.03396R0
For RM as % predicted: a=73?277+0?02746RM
For Fn as % predicted: a=74?2578+0?02626Fn
